JP2017001966A5 - - Google Patents

Download PDF

Info

Publication number
JP2017001966A5
JP2017001966A5 JP2015114599A JP2015114599A JP2017001966A5 JP 2017001966 A5 JP2017001966 A5 JP 2017001966A5 JP 2015114599 A JP2015114599 A JP 2015114599A JP 2015114599 A JP2015114599 A JP 2015114599A JP 2017001966 A5 JP2017001966 A5 JP 2017001966A5
Authority
JP
Japan
Prior art keywords
composition
vitamin
blood
suppressing
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015114599A
Other languages
Japanese (ja)
Other versions
JP2017001966A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2015114599A priority Critical patent/JP2017001966A/en
Priority claimed from JP2015114599A external-priority patent/JP2017001966A/en
Publication of JP2017001966A publication Critical patent/JP2017001966A/en
Publication of JP2017001966A5 publication Critical patent/JP2017001966A5/ja
Pending legal-status Critical Current

Links

Claims (5)

難消化性デキストリンと、松樹皮抽出物、コラーゲン、ペクチン、タンニン、アラニン、バリン、ビタミンＡ、ビタミンＢ１、ナイアシン、パントテン酸ナトリウム、ビタミンＥ、セレン化合物、及び大麦若葉処理物からなる群より選ばれる少なくとも１種の成分とを有効成分として含有することを特徴とする血中中性脂肪上昇抑制組成物。 Selected from the group consisting of indigestible dextrin, pine bark extract, collagen, pectin, tannin, alanine, valine, vitamin A, vitamin B1, niacin, sodium pantothenate, vitamin E, selenium compound, and barley young leaves A composition for suppressing an increase in blood neutral fat, comprising at least one component as an active ingredient. 有効成分を添加して得たことを特徴とする請求項１記載の血中中性脂肪上昇抑制組成物。   The composition for suppressing blood triglyceride elevation according to claim 1, obtained by adding an active ingredient. 難消化性デキストリン及び他の有効成分の配合質量比が、０．５：１〜７０：１の範囲であることを特徴とする請求項１又は２記載の血中中性脂肪上昇抑制組成物。   The composition for inhibiting the increase in blood neutral fat according to claim 1 or 2, wherein the blending mass ratio of the indigestible dextrin and other active ingredients is in the range of 0.5: 1 to 70: 1. 錠剤、カプセル剤、粉末剤、顆粒剤、又は液剤であることを特徴とする請求項１〜３のいずれか記載の血中中性脂肪上昇抑制組成物。   The composition for inhibiting blood neutral fat elevation according to any one of claims 1 to 3, wherein the composition is a tablet, capsule, powder, granule, or liquid. 請求項１〜４のいずれか記載の血中中性脂肪上昇抑制組成物を摂取させることを特徴とする血中中性脂肪上昇抑制方法（ただし、医療行為を除く）。   A method for suppressing blood triglyceride elevation, wherein the composition for inhibiting blood triglyceride elevation according to any one of claims 1 to 4 is ingested (except for medical practice).
JP2015114599A 2015-06-05 2015-06-05 Blood triglyceride elevation-inhibiting composition Pending JP2017001966A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015114599A JP2017001966A (en) 2015-06-05 2015-06-05 Blood triglyceride elevation-inhibiting composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015114599A JP2017001966A (en) 2015-06-05 2015-06-05 Blood triglyceride elevation-inhibiting composition

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019118375A Division JP6753618B2 (en) 2019-06-26 2019-06-26 Composition for suppressing increase in triglyceride in blood

Publications (2)

Publication Number Publication Date
JP2017001966A JP2017001966A (en) 2017-01-05
JP2017001966A5 true JP2017001966A5 (en) 2019-03-14

Family

ID=57751262

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015114599A Pending JP2017001966A (en) 2015-06-05 2015-06-05 Blood triglyceride elevation-inhibiting composition

Country Status (1)

Country Link
JP (1) JP2017001966A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7464932B2 (en) * 2020-07-06 2024-04-10 国立大学法人北海道大学 Pancreatic lipase inhibitor derived from young barley leaves, lipid absorption suppressant, and food and beverage containing the same
JP7290369B2 (en) * 2020-08-11 2023-06-13 株式会社東洋新薬 Blood triglyceride elevation suppressing composition
JP2023106548A (en) * 2022-03-30 2023-08-01 株式会社東洋新薬 Blood triglyceride elevation suppressing composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004175680A (en) * 2002-11-25 2004-06-24 Marine Bio Kk Mineral-containing composition having improving effect on biological balance
JP2004175719A (en) * 2002-11-27 2004-06-24 Toyo Shinyaku:Kk Lifestyle-related disease prevention agent
JP2006022082A (en) * 2003-11-17 2006-01-26 Toyo Shinyaku:Kk Lipid metabolism improver
JP2007308373A (en) * 2004-06-03 2007-11-29 Toyo Shinyaku:Kk Intestinal flora improving agent
JP4352029B2 (en) * 2004-07-26 2009-10-28 株式会社東洋新薬 healthy food
JP2010159283A (en) * 2010-03-19 2010-07-22 Toyo Shinyaku Co Ltd Proanthocyanidin-containing composition
JP2012019762A (en) * 2010-07-16 2012-02-02 Toyo Shinyaku Co Ltd Composition for suspension
JP6043923B2 (en) * 2010-12-08 2016-12-14 株式会社東洋新薬 Inhibitors of blood triglycerides associated with dietary intake

Similar Documents

Publication Publication Date Title
NZ741022A (en) Flavonoid compositions and methods of use
MY173960A (en) Compositions for balancing gut microbiota and the preparation and the uses thereof
CN108026053A8 (en) Condensed glyoxaline compound as mIDH1 inhibitor
NZ729290A (en) Composition containing a mixture of plant extracts or a mixture of molecules contained in said plants, and use for controlling carbohydrate and/or lipid metabolism
WO2012084624A9 (en) Compositions of fat-soluble active ingredients containing plant protein-soy polysaccharide complexes
JP2019501639A5 (en)
WO2015159272A3 (en) Curcumin compositions and uses thereof
JP2015131825A5 (en)
CN104366654A (en) New rosemary composite natural antioxidant
RU2018111036A (en) COMPOSITIONS CONTAINING ECHINACEA EXTRACT AND DERIVATIVES OF LINOIC ACID
RU2011129991A (en) COMPOSITIONS, INCLUDING ZINGIBER OFFICINALE LIPOPHILIC EXTRACT AND CYNARA SCOLYMUS EXTRACT, WHICH ARE USED FOR PREVENTION AND TREATMENT OF GASTROESOPHAGEAL REFLUX AND SYMPTOMY
JP2017001966A5 (en)
JP2017014155A5 (en)
WO2012050397A3 (en) Pharmaceutical composition including herbal medicine extract for preventing or treating kidney cancer
SI2906233T1 (en) Formulations for the treatment and prevention of obesity
RU2015154451A (en) Composition for improving sperm quality in a male subject
JP2016210757A5 (en)
WO2016190566A3 (en) Pharmaceutical composition or functional health food for preventing and treating metabolic diseases, containing water extract of pleurotus eryngii var. ferulae (pf.) as active ingredient
WO2016085321A3 (en) Composition comprising a pentose and polyphenolic compound
JP2014012659A5 (en)
JP2017008001A5 (en)
JP2017014164A5 (en)
JP2017012144A5 (en)
EA201390844A1 (en) COMPLEX COMPOSITION CONTAINING LERCANIDIPINE HYDROCHLORIDE AND VALSARTAN AND METHOD FOR ITS PREPARATION
WO2018093237A3 (en) Composition comprising formic acid or pharmaceutically acceptable salt thereof as active ingredient for preventing or treating obesity or metabolic syndromes caused by obesity